Regular screenings in a traditional setting can help catch breast, cervical, colorectal, and lung cancers early. But other aggressive cancers, like pancreatic and ovarian cancers, are often discovered much later, when treatment is harder and the prognosis looks very different. This reality doesn’t match the rate of innovation in cancer screening, which has changed significantly since I started my career.
Starting today, we’re introducing the Hims & Hers Multi-Cancer Test by Galleri®. It’s a simple blood test that can screen for 50+ types of cancer, including those without recommended screenings. With this test, you can proactively screen for cancers that can develop even before symptoms appear.1 Powered by innovation from GRAIL, we’re offering more people access to multi-cancer early detection technology that can give them the information they need to act early.2
{inline-gallery}
You can add this powerful, cutting-edge test onto your existing Labs plan today.3 We plan to continue expanding the specialized tests available through Labs as a part of helping everyone access a clearer, more actionable picture of their health with access to support, education, and guidance every step of the way.
More than one in three people will develop cancer in their lifetime.4 It’s time we make it easier for more people to tackle health challenges when treatment can potentially be more manageable and successful. At Hims & Hers, we believe knowing more gives you the power to do more. That’s why we’re building a future where you can be in control of your health and wellness journey. We’re here to be your partner through it all.
Important Galleri Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory/Test Information
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.
1 Klein, E. A., Richards, D., Cohn, A., Tummala, M., Lapham, R., Cosgrove, D., Chung, G., Clement, J., Gao, J., Hunkapiller, N., Jamshidi, A., Kurtzman, K. N., Seiden, M. V., Swanton, C., & Liu, M. C. (2021). Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Annals of oncology : official journal of the European Society for Medical Oncology, 32(9), 1167–1177.
2 The Galleri test does not detect a signal for all cancers, and false positive and false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.
3 Not available in all 50 states. Eligibility and rx required. Test is not FDA approved. Use is recommended for adults with an elevated risk for cancer, such as those 50 and older. The test is a screening test that looks for a signal sometimes associated with cancer. It does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Test should be used in addition to healthcare provider recommended screening tests. We recommend talking to your healthcare provider to determine if additional testing is needed. For more important safety and laboratory/test information, please click here.
